Fenofibrate
Showing 26 - 50 of 218
Diabetes, Diabetic Nephropathies Trial in Singapore (Fenofibrate)
Recruiting
- Diabetes Mellitus
- Diabetic Nephropathies
- Fenofibrate
-
Singapore, SingaporeSingapore General Hospital
Dec 10, 2020
Diabetic Retinopathy Trial in United States (Fenofibrate, Placebo)
Recruiting
- Diabetic Retinopathy
- Fenofibrate 160mg
- Placebo
-
Glendale, California
- +32 more
Jan 26, 2022
Nonalcoholic Steatohepatitis (NASH) Trial in United States (Firsocostat, Fenofibrate)
Completed
- Nonalcoholic Steatohepatitis (NASH)
- Firsocostat
- Fenofibrate
-
Tustin, California
- +4 more
Nov 23, 2020
Neonatal Jaundice Trial (Fenofibrate, Placebo)
Completed
- Neonatal Jaundice
- Fenofibrate
- Placebo
- (no location specified)
Jun 2, 2020
HIV, Lipodystrophy Trial in Puerto Rico, United States (Pravastatin sodium, Fenofibrate)
Completed
- HIV Infections
- Lipodystrophy
- Pravastatin sodium
- Fenofibrate
-
Birmingham, Alabama
- +57 more
Oct 28, 2021
Non Familial Chylocmicronemia Syndrome (Non-FCS) Trial in Canada, Russian Federation, United States (LCQ908, Fenofibrate, Fish
Completed
- Non Familial Chylocmicronemia Syndrome (Non-FCS)
- LCQ908
- +5 more
-
Muscle Shoals, Alabama
- +31 more
Dec 11, 2020
Hyperlipidemia Trial in China (K-877 0.1 mg tablet, Fenofibrate 200 mg capsule, Placebo tablet)
Recruiting
- Hyperlipidemia
- K-877 0.1 mg tablet
- +3 more
-
Anhui, China
- +32 more
Dec 8, 2021
Fenofibrate and Pharmacogenetic Impact in Dyslipidemia
Completed
- Dyslipidemia
- fenofibrate
-
Minneapolis, MinnesotaUniversity of Minnesota
Jan 9, 2020
Dyslipidemia Trial in Chicago (LCP-AtorFen, atorvastatin, fenofibrate)
Completed
- Dyslipidemia
- LCP-AtorFen
- +2 more
-
Chicago, IllinoisRadiant Research, 515 N State Street, Suite 2700
Feb 4, 2020
Diabetes, Diabetic Retinopathy Trial in Padova (Fenofibrate 145 mg, Placebo)
Completed
- Diabetes
- Diabetic Retinopathy
- Fenofibrate 145 mg
- Placebo
-
Padova, ItalyUniversity Hospital of Padova, Diabetes Outpatient Clinic
Dec 17, 2019
Burn Trial in Galveston (Fenofibrate, Placebo, Propranolol)
Terminated
- Burn
- Fenofibrate
- +2 more
-
Galveston, TexasShriners Hospitals for Children
Nov 26, 2019
Second or Third Degree Burns Trial in Galveston (Fenofibrate, Sugar Pill)
Terminated
- Second or Third Degree Burns
- Fenofibrate
- Sugar Pill
-
Galveston, TexasUniversity of Texas Medical Branch
Nov 26, 2019
Dyslipidemia Trial in Chicago (LCP-AtorFen)
Completed
- Dyslipidemia
-
Chicago, IllinoisRadiant Research, 515 N State St, Suite 2700
Mar 2, 2020
Effectiveness in Patients With Metabolic Syndrome (TRISTAN)
Completed
- Hypertriglyceridemia
- Metabolic Syndrome
- Tricor (fenofibrate), 145 mg, film-coated tablet
-
Barnaul, Russian Federation
- +62 more
Dec 14, 2021
HIV, Fenofibrate, Protease Inhibitors Trial run by the CC (Fenofibrate, Ritonavir, Lopinavir/Ritonavir)
Completed
- HIV
- +4 more
- Fenofibrate
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 6, 2019
Hypercholesterolemia Trial in Worldwide (Alirocumab SAR236553 (REGN727), Atorvastatin, Simvastatin)
Completed
- Hypercholesterolemia
- Alirocumab SAR236553 (REGN727)
- +11 more
-
Sao Paulo, Brazil
- +9 more
Dec 2, 2020
Atherogenic Dyslipidemia, Obesity Associated Disorder Trial in Baghdad (other, drug, dietary supplement)
Completed
- Atherogenic Dyslipidemia
- Obesity Associated Disorder
- Therapeutic Lifestyle Changes
- +3 more
-
Baghdad, Iraq
- +1 more
Sep 2, 2019
Severe Hypertriglyceridemia Trial in Worldwide (K-877, Fenofibrate, Placebo (for K-877))
Severe Hypertriglyceridemia Trial in Worldwide (K-877, Fenofibrate, Placebo (for K-877))
Spinal Cord Injury, Dyslipidemia Trial in West Orange, Bronx (Fenofibrate, No intervention)
Completed
- Spinal Cord Injury
- Dyslipidemia
- Fenofibrate
- No intervention
-
West Orange, New Jersey
- +1 more
Jun 7, 2019
Diabetic Retinopathy Trial (Simvastatin 40mg, Fenofibrate 200mg, Omega 3 fatty acid)
Unknown status
- Diabetic Retinopathy
- Simvastatin 40mg
- +2 more
- (no location specified)
Jan 15, 2020
Hypercholesterolaemia Trial in Worldwide (Alirocumab SAR236553 (REGN727), Rosuvastatin, Atorvastatin)
Active, not recruiting
- Hypercholesterolaemia
- Alirocumab SAR236553 (REGN727)
- +12 more
-
Boca Raton, Florida
- +45 more
Jan 12, 2022
Coronary Artery Disease Trial in Korea, Republic of (Rosuvastatin and fenofibrate, Rosuvastatin alone)
Unknown status
- Coronary Artery Disease
- Rosuvastatin and fenofibrate
- Rosuvastatin alone
-
Daejeon, Korea, Republic of
- +5 more
May 12, 2019
Dyslipidemias Trial in Hwaseong-si (Fenofibrate)
Unknown status
- Dyslipidemias
- Fenofibrate
-
Hwaseong-si, Korea, Republic ofHallym University Dongtan Sacred Heart Hospital
Mar 13, 2019
Dyslipidemias, Hyperlipidemias, Liver Transplant Disorder Trial in Moscow (Pitavastatin, PCSK9 inhibitor)
Recruiting
- Dyslipidemias
- +5 more
- Pitavastatin
- PCSK9 inhibitor
-
Moscow, Russian FederationNational Medical Research Centre for Therapy and Preventive Medi
Sep 8, 2022